Skip to main content

Newsroom press releases

12/12/17 - 13:15

DiaSorin launches a new SIMPLEXA BORDETELLA DIRECT molecular test (426.89 KB)
Products Molecular

29/11/17 - 19:30

Resignation of a Strategic Executive of the Company (233.58 KB)
Other

09/11/17 - 14:15

GROWTH IN REVENUES AND NET PROFIT IN Q3 2017. STRONG FREE CASH FLOW GENERATION. 2017 GUIDANCE CONFIRMED (1001.87 KB)
Financial Data

29/09/17 - 15:00

DiaSorin revises its guidance upwards for 2019 as a consequence of the completion of the acquisition of ELISA immunodiagnostic business portfolio and associated assets from SIEMENS (928.39 KB)
Financial Data

29/09/17 - 14:15

DiaSorin completes the acquisition of the ELISA immunodiagnostic business portfolio and associated assets from SIEMENS HEALTHINEERS (332.93 KB)
Acquisition / Partnership

21/09/17 - 12:45

DiaSorin earned CE-mark extending sample claims for DiaSorin Molecular's Simplexa HSV 1 & 2 kit (738.62 KB)
Products Molecular

03/08/17 - 14:45

DiaSorin Group reports strong growth in revenues and profitability in Q2 2017 (1015.93 KB)
Financial Data

28/07/17 - 14:45

DiaSorin launches 3 new primer pairs for use in molecular testing: PNEUMOCYSTIS JIROVECII, GROUP C STREPTOCOCCUS, and GROUP G STREPTOCOCCUS (427.51 KB)
Products Molecular

25/07/17 - 21:00

DiaSorin to acquire ELISA immunodiagnostic business portfolio and associated assets from SIEMENS HEALTHINEERS (443.45 KB)
Acquisition / Partnership

10/07/17 - 13:30

DiaSorin launches IAM CBFB-MYH11, completing the diagnostic test menu for molecular screening of acute myeloid leukemia by Q-LAMP (197.68 KB)
Products Molecular

26/06/17 - 9:45

DiaSorin presents its 2017-2019 Industrial Plan (479.98 KB)
Financial Data

23/06/17 - 9:30

DiaSorin and TECAN to collaborate in new platform development (755.46 KB)
Acquisition / Partnership

22/06/17 - 19:45

DiaSorin and QIAGEN sign collaboration to expand Liaison test menu through adoption of select QIAGEN assays (430.67 KB)
Acquisition / Partnership

23/05/17 - 11:45

DiaSorin launches the new Liaison SHBG test for the diagnosis of androgen-related disorders (735.43 KB)
Products Immunodiagnostic

16/05/17 - 13:00

DiaSorin launches the new Liaison Androstenedione test for the evaluation of adrenal and gonadal functionality (429.25 KB)
Products Immunodiagnostic

08/05/17 - 19:30

DiaSorin Group reports growth in revenues and profitability in the first quarter 2017, generating a relevant cash flow (984.86 KB)
Financial Data

27/04/17 - 18:45

DiaSorin - Annual General Meeting 2016 (421.04 KB)
Financial Data

21/04/17 - 18:45

DiaSorin receives authorization for the distribution of Zika IgM test in Europe (349.09 KB)
Products Immunodiagnostic

06/04/17 - 18:00

DiaSorin receives FDA Emergency Use Authorization for the first, fully - automated Zika IgM test (376.16 KB)
Products Immunodiagnostic

08/03/17 - 15:30

The Board of Directors approves the results for FY'16 (1.13 MB)
Financial Data

21/02/17 - 11:30

DiaSorin launches its new Simplexa C. Difficile direct molecular test in the US market (430.86 KB)
Products Molecular

26/01/17 - 12:45

DIASORIN LAUNCHES THE LIAISON FGF 23 TEST, THE FIRST INNOVATIVE AND FULLY AUTOMATED MARKER FOR CHRONIC KIDNEY DISEASE (140.98 KB)
Products Immunodiagnostic

22/12/10 - 1:00

2011 Financial calendar (180.28 KB)
Financial Data

20/12/10 - 1:00

Dividend may be distributed in June (445.78 KB)
Financial Data

02/12/10 - 1:00

Comment on position Paper on Vitamin D (53.46 KB)
Products Immunodiagnostic

24/11/10 - 1:00

Change in share capital (46.85 KB)
Financial Data

18/11/10 - 1:00

Financial instruments to employees (48.33 KB)
Financial Data

05/11/10 - 1:00

The BoD approves Q3'10 results (414.16 KB)
Financial Data

02/11/10 - 1:00

Change in share capital (313.61 KB)
Financial Data

08/10/10 - 2:00

2010 Financial calendar update (174.1 KB)
Financial Data

30/09/10 - 2:00

Change in share capital (5.25 KB)
Financial Data

24/09/10 - 2:00

Financial instruments to employees (48.81 KB)
Financial Data

16/09/10 - 2:00

Stock options exercised by key managers (195.67 KB)
Financial Data

02/09/10 - 2:00

Financial instruments to employees (24.27 KB)
Financial Data

06/08/10 - 2:00

The BoD approves H1'10 results (287.11 KB)
Financial Data

07/07/10 - 2:00

Agreement with Meridian Inc. (182.7 KB)
Acquisition / Partnership

06/07/10 - 2:00

2010 Financial calendar update (174.1 KB)
Financial Data

02/07/10 - 2:00

Financial instruments to employees (24.37 KB)
Financial Data

01/06/10 - 2:00

Acquisition of MUREX product line (102.6 KB)
Acquisition / Partnership

14/05/10 - 2:00

The BoD approves Q1'10 results (254.05 KB)
Financial Data

27/04/10 - 2:00

Approval of statutory financial statements (182.99 KB)
Financial Data

20/04/10 - 2:00

2010 Financial calendar update (168.23 KB)
Financial Data

14/04/10 - 2:00

Postponement of the term for lists of members of the Board of Auditors (40.34 KB)
Financial Data

09/04/10 - 2:00

China approves new prenatal screening product line on LIAISON (141.08 KB)
Products Immunodiagnostic

02/04/10 - 2:00

Financial instruments to employees (27.79 KB)
Financial Data

22/03/10 - 1:00

The BoD approves FY 2009 results (306.02 KB)
Financial Data

10/03/10 - 1:00

Acquisition of MUREX product line (45.5 KB)
Acquisition / Partnership

01/03/10 - 1:00

2010 Financial calendar update (192.49 KB)
Financial Data

12/02/10 - 1:00

The BoD approves Q4'09 results (213.8 KB)
Financial Data

18/01/10 - 1:00

2010 Financial calendar (103 KB)
Financial Data